Biocon Biologics
Winny Singh is a dedicated professional with extensive experience in the biopharmaceutical industry, specializing in R&D Technical Operations. With a strong background in research and program management, Winny has worked at various companies such as Biocon Biologics, Stelis Biopharma, and Ranbaxy. Winny holds a Master of Science in Applied Microbiology and Biotechnology, along with additional qualifications in business management and a diploma in French language. Currently serving as an Associate Director at Biocon Biologics, Winny excels in implementing best practices, automation, and technology solutions to improve business operations.
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics